These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 19833379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin.
    Fasullo S, Scalzo S, Maringhini G, Ganci F, Cannizzaro S, Basile I, Cangemi D, Terrazzino G, Parrinello G, Sarullo FM, Baglini R, Paterna S, Di Pasquale P.
    Am J Med Sci; 2011 Jan; 341(1):33-9. PubMed ID: 20890176
    [Abstract] [Full Text] [Related]

  • 3. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial.
    Steering Committee.
    Am Heart J; 2012 Jan; 163(1):33-38.e1. PubMed ID: 22172434
    [Abstract] [Full Text] [Related]

  • 4. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.
    Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Hernandez J.
    J Thromb Haemost; 2014 Apr; 12(4):459-68. PubMed ID: 24484241
    [Abstract] [Full Text] [Related]

  • 5. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.
    Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W, Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators.
    N Engl J Med; 2002 Oct 10; 347(15):1143-50. PubMed ID: 12374874
    [Abstract] [Full Text] [Related]

  • 6. Fibrinolysis for patients with intermediate-risk pulmonary embolism.
    Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV, PEITHO Investigators.
    N Engl J Med; 2014 Apr 10; 370(15):1402-11. PubMed ID: 24716681
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
    Li HY, Wang YB, Ren XY, Wang J, Wang HS, Jin YH.
    Pharmacology; 2023 Apr 10; 108(2):111-126. PubMed ID: 36603558
    [Abstract] [Full Text] [Related]

  • 9. Value of transthoracic echocardiography in therapy regimens evaluation in pulmonary embolism.
    Zhu L, Wang C, Yang Y, Wu Y, Zhai Z, Dai H, Pang B, Tong Z.
    J Thromb Thrombolysis; 2008 Dec 10; 26(3):251-6. PubMed ID: 17705052
    [Abstract] [Full Text] [Related]

  • 10. Thrombolytic therapy for submassive pulmonary embolism.
    Lankeit M, Konstantinides S.
    Best Pract Res Clin Haematol; 2012 Sep 10; 25(3):379-89. PubMed ID: 22959553
    [Abstract] [Full Text] [Related]

  • 11. Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism.
    Bagla S, Smirniotopoulos JB, van Breda A, Sheridan MJ, Sterling KM.
    J Vasc Interv Radiol; 2015 Jul 10; 26(7):1001-6. PubMed ID: 25704224
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of tenecteplase in pulmonary embolism.
    Shrivastava S, Sachdeva A, Paul B.
    Indian Heart J; 2009 Jul 10; 61(5):464-6. PubMed ID: 20635764
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recovery of regional right ventricular function after thrombolysis for pulmonary embolism.
    Nass N, McConnell MV, Goldhaber SZ, Chyu S, Solomon SD.
    Am J Cardiol; 1999 Mar 01; 83(5):804-6, A10. PubMed ID: 10080447
    [Abstract] [Full Text] [Related]

  • 18. [Fibrinolysis in pulmonary embolism].
    Thabut G, Jebrak G.
    Presse Med; 2001 Oct 20; 30(30):1501-6. PubMed ID: 11712211
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.
    Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz HR, Bogaerts K, Danays T, Lindahl B, Mäkijärvi M, Verheugt F, Van de Werf F.
    Circulation; 2003 Jul 15; 108(2):135-42. PubMed ID: 12847070
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.